Marshall Wace, LLP Bio Rad Laboratories, Inc. Transaction History

Marshall Wace, LLP

$77.3 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$269.37 - $365.04 $32.1 Million - $43.6 Million	-119,350 Reduced 94.99%	6,300 $2.03 Million
Q3 2023 Nov 14, 2023	BUY	$350.25 - $422.63 $37.1 Million - $44.8 Million	106,037 Added 540.65%	125,650 $45 Million
Q2 2023 Aug 14, 2023	SELL	$359.49 - $486.4 $4.94 Million - $6.69 Million	-13,749 Reduced 41.21%	19,613 $7.44 Million
Q1 2023 May 15, 2023	BUY	$418.69 - $503.0 $13.7 Million - $16.5 Million	32,767 Added 5507.06%	33,362 $16 Million
Q4 2022 Feb 14, 2023	SELL	$351.71 - $456.01 $60.5 Million - $78.4 Million	-172,005 Reduced 99.66%	595 $250,000
Q3 2022 Nov 14, 2022	SELL	$412.59 - $563.26 $21.5 Million - $29.4 Million	-52,169 Reduced 23.21%	172,600 $72 Million
Q2 2022 Aug 15, 2022	SELL	$463.67 - $597.16 $112 Million - $145 Million	-242,574 Reduced 51.9%	224,769 $111 Million
Q1 2022 May 16, 2022	BUY	$524.57 - $735.42 $70.3 Million - $98.5 Million	133,973 Added 40.19%	467,343 $263 Million
Q4 2021 Feb 14, 2022	SELL	$708.84 - $794.68 $75.1 Million - $84.2 Million	-105,974 Reduced 24.12%	333,370 $252 Million
Q3 2021 Nov 15, 2021	BUY	$657.71 - $825.77 $2.79 Million - $3.51 Million	4,245 Added 0.98%	439,344 $328 Million
Q2 2021 Aug 13, 2021	SELL	$576.64 - $649.04 $77.2 Million - $86.9 Million	-133,819 Reduced 23.52%	435,099 $280 Million
Q1 2021 May 17, 2021	BUY	$547.01 - $662.35 $109 Million - $132 Million	199,507 Added 54.01%	568,918 $325 Million
Q4 2020 Feb 16, 2021	BUY	$510.68 - $643.45 $45.4 Million - $57.2 Million	88,844 Added 31.67%	369,411 $215 Million
Q3 2020 Nov 16, 2020	BUY	$454.43 - $535.6 $21.6 Million - $25.4 Million	47,465 Added 20.36%	280,567 $145 Million
Q2 2020 Aug 13, 2020	BUY	$334.87 - $493.06 $40.5 Million - $59.6 Million	120,850 Added 107.66%	233,102 $105 Million
Q1 2020 May 15, 2020	BUY	$320.01 - $409.07 $35.6 Million - $45.6 Million	111,393 Added 12967.75%	112,252 $39.4 Million
Q4 2019 Feb 14, 2020	SELL	$319.73 - $374.2 $24.9 Million - $29.1 Million	-77,897 Reduced 98.91%	859 $318,000
Q3 2019 Nov 14, 2019	BUY	$304.55 - $345.24 $17.4 Million - $19.8 Million	57,281 Added 266.73%	78,756 $26.2 Million
Q2 2019 Aug 14, 2019	BUY	$286.93 - $312.59 $6.16 Million - $6.71 Million	21,475 New	21,475 $6.71 Million
Q1 2019 May 14, 2019	SELL	$224.3 - $317.41 $2.06 Million - $2.92 Million	-9,196 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$220.1 - $309.0 $3.25 Million - $4.56 Million	-14,767 Reduced 61.62%	9,196 $2.14 Million
Q3 2018 Nov 14, 2018	BUY	$289.28 - $326.15 $6.03 Million - $6.8 Million	20,850 Added 669.77%	23,963 $7.5 Million
Q2 2018 Aug 14, 2018	BUY	$244.1 - $303.88 $759,883 - $945,978	3,113 New	3,113 $898,000

Others Institutions Holding BIO

# of Institutions

457

Shares Held

18.2M

Call Options Held

19.5K

Put Options Held

13.9K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.37B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account